列线图预测鼻咽癌原发远处转移以指导FDG PET/CT个体化应用
本研究基于3591例病理确诊鼻咽癌患者建立列线图预测原发远处转移(DM),建模队列1922例(2007-2014年),验证队列1669例(2015-2016年)。模型纳入性别、N分期、EBV DNA、LDH和血红蛋白,训练与验证C-index分别为0.796和0.779,推荐以3.5%阈值指导PET/CT应用。
要点
- 列线图可预测鼻咽癌原发远处转移,训练C-index 0.796,验证0.779。
- 预测因子包括性别、N分期、EBV DNA、LDH和血红蛋白。
- 推荐以3.5%阈值概率指导初诊分期时PET/CT的个体化应用。
核心结论
- 列线图是预测鼻咽癌原发远处转移并指导初诊分期时PET/CT个体化应用的有用工具。
研究设计与样本
- 连续纳入3591例病理确诊鼻咽癌患者,基于2007-2014年治疗的1922例构建列线图,并在2015-2016年纳入的1669例中验证。
主要发现
- 3591例中355例发生原发远处转移,发生率为9.9%。
- 性别、N分期、EBV DNA水平、乳酸脱氢酶水平和血红蛋白水平是原发远处转移的独立预测因素。
- 训练队列C-index为0.796(95% CI,0.76-0.83),验证队列为0.779(95% CI,0.74-0.81)。
- NRI指数显示该模型预测性能优于血浆EBV DNA水平和N分期。
关键数值与推荐
- 基于临床效用分析,推荐以3.5%的阈值概率指导PET/CT的应用。
临床怎么用
- 初诊分期时可使用该列线图预测鼻咽癌原发远处转移风险,并以3.5%阈值概率个体化决定是否应用PET/CT。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to establish an effective nomogram to predict primary distant metastasis (DM) in patients with nasopharyngeal carcinoma (NPC) to guide the application of PET/CT. METHODS: In total, 3591 patients with pathologically confirmed NPC were consecutively enrolled. The nomogram was constructed based on 1922 patients treated between 2007 and 2014. Multivariate logistical regression was applied to identify the independent risk factors of DM. The predictive value of the nomogram was evaluated using the concordance index (C-index), calibration curve, probability density functions (PDFs), and clinical utility curve (CUC). The results were validated in 1669 patients enrolled from 2015 to 2016. Net reclassification improvement (NRI) was applied to compare performances of the nomogram with other clinical factors. The best cut-off value of the nomogram chosen for clinical application was analyzed. RESULTS: A total of 355 patients showed primary DM among 3591 patients, yielding an incidence rate of 9.9%. Sex, N stage, EBV DNA level, lactate dehydrogenase level, and hemoglobin level were independent predictive factors for primary DM. C-indices in the training and validation cohort were 0.796 (95% CI, 0.76-0.83) and 0.779 (95% CI, 0.74-0.81), respectively. The NRI indices demonstrated that this model had better predictive performance than plasma EBV DNA level and N stage. We advocate for a threshold probability of 3.5% for guiding the application of PET/CT depending on the clinical utility analyses. CONCLUSION: This nomogram is a useful tool to predict primary DM of NPC and guide the clinical application of PET/CT individually at the initial staging.
引用
- Xiao BB, Lin DF, Sun XS, et al. Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT. Eur J Nucl Med Mol Imaging. 2021. PMID: 33420610. doi:10.1007/s00259-020-05128-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。